Success of Adoptive Cell Therapy in ALL Could Be Applied to Myeloma – Cancer Therapy Advisor
Cancer Therapy Advisor |
Success of Adoptive Cell Therapy in ALL Could Be Applied to Myeloma
Cancer Therapy Advisor The US Food and Drug Administration (FDA) recently approved the first adoptive cell therapy for the treatment of cancer.1 Tisagenlecleucel is a chimeric antigen receptor (CAR)-T cell therapy approved for some pediatric and young adult patients with … Significant Number of B-cell Maturation Antigen (BCMA) Targeted Therapies in Pipeline is Expected to Boost Market … |
